Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23925703 | 0.80 | KDM4E (0.37) | AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL23926010 | 0.76 | AKR1B1 (0.39) | AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL23925910 | 0.76 | CYP1A2 (0.38) | AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL23925701 | 0.75 | NPSR1 (0.38) | AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL23925818 | 0.69 | KDM4E (0.34) | KDM4EALDH1A1HPGD | |
| SCHEMBL23926093 | 0.67 | AKR1B1 (0.39) | AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL6836815 | 0.67 | HDAC1 (0.37) | AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL13495858 | 0.66 | AKR1B1 (0.44) | AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL23925921 | 0.65 | CA12 (0.41) | KDM4EALDH1A1HPGD | |
| SCHEMBL20734708 | 0.65 | AKR1B1 (0.45) | AKR1B1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230117370-A1 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | OREGON STATE UNIVERSITY (US) | 2023-04-20 | — | — | US | claimed |
| WO-2021211982-A2 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | OREGON STATE UNIVERSITY (US) | 2021-10-21 | — | — | WO | claimed |
| US-20230117370-A1 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | OREGON STATE UNIVERSITY (US) | 2023-04-20 | — | — | US | disclosed |
| WO-2021211982-A2 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | OREGON STATE UNIVERSITY (US) | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230117370-A1 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | CYP2B6, TYR, CYP2D6 | AKR1B1 1363/4885KDM4E 1082/4885ALDH1A1 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.